You are here

AusPAR: Tafamidis and Tafamidis meglumine

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

10 September 2020
AusPAR Details
AusPAR
Active Ingredient
Tafamidis and Tafamidis meglumine
Product Name
Vyndamax and Vyndaqel
Sponsor
Pfizer Australia Pty Ltd
Submission Number
PM-2019-00391-1-3 and PM-2019-01399-1-3
Submission Type
New chemical entity
Decision
Approved
AusPAR Date
3 September 2020
Publication Date

10 September 2020